# CSDC2

## Overview
CSDC2 is a gene that encodes the cold shock domain-containing protein C2, also known as PIPPin, which is a member of the cold shock domain (CSD) protein family. This protein is characterized by its ability to bind RNA, particularly in the brain, where it plays a crucial role in the post-transcriptional regulation of histone mRNAs. The CSDC2 protein contains a central cold shock domain that facilitates interaction with single-stranded nucleic acids and a proline-rich PIP motif that may be involved in binding double-stranded RNA. It is active in both the cytoplasm and nucleus of nerve cells, suggesting a role in the regulation of mRNA from transcription to translation. Beyond its neurological functions, CSDC2 is also involved in the regulation of decidualization during pregnancy and has been implicated in various cancers, including colorectal and prostate cancer, where it serves as a potential prognostic biomarker (Nastasi1999PIPPin; Vallejo2018CSDC2; Heinemann2021ColdShock; Mo2019Identification; Xing2021A).

## Function
CSDC2, also known as PIPPin, is a cold shock domain-containing protein that plays a significant role in RNA binding and regulation within mammalian cells. It is particularly enriched in the brain, where it binds specifically to the 3' untranslated regions (UTRs) of mRNAs encoding rare histone variants, such as H1° and H3.3. This binding is thought to be involved in the post-transcriptional regulation of these histone variants, which is crucial during brain development (Heinemann2021ColdShock; Nastasi1999PIPPin).

CSDC2 contains a central cold shock domain (CSD) that facilitates its interaction with single-stranded nucleic acids, and a proline-rich PIP motif that is presumably involved in double-stranded RNA binding (Heinemann2021ColdShock). The protein is active in both the cytoplasm and nucleus of nerve cells, with its RNA-binding activity primarily confined to the nucleus. This suggests that CSDC2 may accompany histone mRNAs from transcription to translation, potentially affecting their polyadenylation and translation (Nastasi1999PIPPin).

In addition to its role in the brain, CSDC2 is implicated in the regulation of decidualization during pregnancy, where its expression is linked to the differentiation of specific decidual areas, influencing the balance between cell proliferation and differentiation (Vallejo2018CSDC2).

## Clinical Significance
CSDC2 has been implicated in various diseases due to its role in RNA binding and regulation. In early-onset colorectal cancer (CRC), CSDC2 is identified as a significant prognostic factor. Its expression levels are associated with overall survival time in early-onset CRC patients, suggesting its potential as a diagnostic biomarker for this condition (Mo2019Identification).

In prostate cancer, CSDC2 is part of a 13 RNA-binding protein signature used to predict biochemical recurrence (BCR). The expression of CSDC2, along with other proteins, is used in a predictive model that has shown strong capability in forecasting BCR outcomes, indicating its potential clinical application in monitoring prostate cancer progression (Xing2021A). However, CSDC2 is downregulated in prostate cancer tissues compared to normal tissues, which may affect its utility as a biomarker in certain contexts (Xing2021A).

These findings highlight the clinical significance of CSDC2 in cancer, where alterations in its expression or interactions can impact disease prognosis and treatment strategies. Further research is needed to fully understand its role and potential as a therapeutic target.

## Interactions
CSDC2, also known as PIPPin, is a mammalian brain-specific protein that interacts with nucleic acids, particularly binding to histone mRNA. It is known to bind specifically to the 3' untranslated region (UTR) of nuclear transcripts encoding rare histone variants, suggesting a role in the regulation of histone mRNA during brain development (Heinemann2021ColdShock). The protein contains a central cold shock domain (CSD) and a proline-rich PIP motif, which is presumed to bind double-stranded RNA (Heinemann2021ColdShock).

CSDC2 is also involved in transcriptional regulation, as it is induced by microRNA miR-373 and pre-miR-373, where the microRNA plays an unexpected role in transcription activation (Heinemann2021ColdShock). In the context of decidualization, CSDC2 binds with high specificity to transcripts encoding H1° and H3.3 histone variants, potentially inhibiting their polyadenylation and translation, which suggests a regulatory role in downregulating histone levels during brain development (Vallejo2018CSDC2). These interactions highlight CSDC2's involvement in complex regulatory networks, influencing gene expression and cellular differentiation processes.


## References


[1. (Nastasi1999PIPPin) Tommaso Nastasi, Maria Scaturro, Marianna Bellafiore, Lavinia Raimondi, Simone Beccari, Alessandro Cestelli, and Italia Di Liegro. Pippin is a brain-specific protein that contains a cold-shock domain and binds specifically to h1° and h3.3 mrnas. Journal of Biological Chemistry, 274(34):24087–24093, August 1999. URL: http://dx.doi.org/10.1074/jbc.274.34.24087, doi:10.1074/jbc.274.34.24087. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.274.34.24087)

[2. (Vallejo2018CSDC2) Griselda Vallejo, Ana Cecilia Mestre‐Citrinovitz, Elke Winterhager, and Patricia Esther Saragüeta. Csdc2, a cold shock domain rna‐binding protein in decidualization. Journal of Cellular Physiology, 234(1):740–748, August 2018. URL: http://dx.doi.org/10.1002/jcp.26885, doi:10.1002/jcp.26885. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.26885)

[3. (Heinemann2021ColdShock) Udo Heinemann and Yvette Roske. Cold-shock domains—abundance, structure, properties, and nucleic-acid binding. Cancers, 13(2):190, January 2021. URL: http://dx.doi.org/10.3390/cancers13020190, doi:10.3390/cancers13020190. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13020190)

[4. (Mo2019Identification) Xiaoqiong Mo, Zexin Su, Bingsheng Yang, Zhirui Zeng, Shan Lei, and Hui Qiao. Identification of key genes involved in the development and progression of early‑onset colorectal cancer by co‑expression network analysis. Oncology Letters, November 2019. URL: http://dx.doi.org/10.3892/ol.2019.11073, doi:10.3892/ol.2019.11073. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2019.11073)

[5. (Xing2021A) Qianwei Xing, Shouyong Liu, Jiaochen Luan, Yi Wang, and Limin Ma. A novel 13 rna binding proteins (rbps) signature could predict prostate cancer biochemical recurrence. Pathology - Research and Practice, 225:153587, September 2021. URL: http://dx.doi.org/10.1016/j.prp.2021.153587, doi:10.1016/j.prp.2021.153587. This article has 9 citations.](https://doi.org/10.1016/j.prp.2021.153587)